High levels of TrkA and TrkC is expressed in biologically favourable neuroblastoma while high levels of TrkB and its ligand BDNF is expressed in biologically unfavourable aggressive neuroblastoma with MYCN amplification [51,52]. The gene discussed is MYCN; the disease is neuroblastoma.